229 related articles for article (PubMed ID: 28240291)
1. Residual Effects of THC via Novel Measures of Brain Perfusion and Metabolism in a Large Group of Chronic Cannabis Users.
Filbey FM; Aslan S; Lu H; Peng SL
Neuropsychopharmacology; 2018 Mar; 43(4):700-707. PubMed ID: 28240291
[TBL] [Abstract][Full Text] [Related]
2. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
[TBL] [Abstract][Full Text] [Related]
3. Functional imaging studies in cannabis users.
Chang L; Chronicle EP
Neuroscientist; 2007 Oct; 13(5):422-32. PubMed ID: 17901252
[TBL] [Abstract][Full Text] [Related]
4. Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study.
van Hell HH; Bossong MG; Jager G; Kristo G; van Osch MJ; Zelaya F; Kahn RS; Ramsey NF
Int J Neuropsychopharmacol; 2011 Nov; 14(10):1377-88. PubMed ID: 21489346
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic effects of Δ
Ogunbiyi MO; Hindocha C; Freeman TP; Bloomfield MAP
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109900. PubMed ID: 32109508
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype.
Bossong MG; van Hell HH; Schubart CD; van Saane W; Iseger TA; Jager G; van Osch MJP; Jansma JM; Kahn RS; Boks MP; Ramsey NF
Eur Neuropsychopharmacol; 2019 Jun; 29(6):766-776. PubMed ID: 30975584
[TBL] [Abstract][Full Text] [Related]
7. Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing.
Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
Exp Clin Psychopharmacol; 2018 Dec; 26(6):582-598. PubMed ID: 30138003
[TBL] [Abstract][Full Text] [Related]
8. Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [
Boileau I; Mansouri E; Williams B; Le Foll B; Rusjan P; Mizrahi R; Tyndale RF; Huestis MA; Payer DE; Wilson AA; Houle S; Kish SJ; Tong J
Biol Psychiatry; 2016 Nov; 80(9):691-701. PubMed ID: 27345297
[TBL] [Abstract][Full Text] [Related]
9. Neuroimaging in cannabis use: a systematic review of the literature.
Martín-Santos R; Fagundo AB; Crippa JA; Atakan Z; Bhattacharyya S; Allen P; Fusar-Poli P; Borgwardt S; Seal M; Busatto GF; McGuire P
Psychol Med; 2010 Mar; 40(3):383-98. PubMed ID: 19627647
[TBL] [Abstract][Full Text] [Related]
10. Interindividual and regional relationship between cerebral blood flow and glucose metabolism in the resting brain.
Henriksen OM; Vestergaard MB; Lindberg U; Aachmann-Andersen NJ; Lisbjerg K; Christensen SJ; Rasmussen P; Olsen NV; Forman JL; Larsson HBW; Law I
J Appl Physiol (1985); 2018 Oct; 125(4):1080-1089. PubMed ID: 29975605
[TBL] [Abstract][Full Text] [Related]
11. Regional difference in cerebral blood flow and oxidative metabolism in human cortex.
Ishii K; Sasaki M; Kitagaki H; Sakamoto S; Yamaji S; Maeda K
J Nucl Med; 1996 Jul; 37(7):1086-8. PubMed ID: 8965174
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal harms, protection and recovery following regular cannabis use.
Yücel M; Lorenzetti V; Suo C; Zalesky A; Fornito A; Takagi MJ; Lubman DI; Solowij N
Transl Psychiatry; 2016 Jan; 6(1):e710. PubMed ID: 26756903
[TBL] [Abstract][Full Text] [Related]
13. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.
Ceccarini J; Kuepper R; Kemels D; van Os J; Henquet C; Van Laere K
Addict Biol; 2015 Mar; 20(2):357-67. PubMed ID: 24373053
[TBL] [Abstract][Full Text] [Related]
14. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
15. Frontal lobe dysfunction in long-term cannabis users.
Lundqvist T; Jönsson S; Warkentin S
Neurotoxicol Teratol; 2001; 23(5):437-43. PubMed ID: 11711246
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
[TBL] [Abstract][Full Text] [Related]
17. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J
Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500
[TBL] [Abstract][Full Text] [Related]
18. [Cerebral blood flow, cerebral blood volume, oxygen utilization and oxygen extraction fraction: the influence of age].
Zhang Y; Peng YY; Chen GY; Chen WF
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1237-9. PubMed ID: 20584645
[TBL] [Abstract][Full Text] [Related]
19. Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes.
Ramaekers JG; van Wel JH; Spronk D; Franke B; Kenis G; Toennes SW; Kuypers KP; Theunissen EL; Stiers P; Verkes RJ
Brain Imaging Behav; 2016 Dec; 10(4):1254-1263. PubMed ID: 26667034
[TBL] [Abstract][Full Text] [Related]
20. Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography.
Mathew RJ; Wilson WH; Turkington TG; Hawk TC; Coleman RE; DeGrado TR; Provenzale J
Psychiatry Res; 2002 Dec; 116(3):173-85. PubMed ID: 12477601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
